BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25406809)

  • 21. Prognostic value of post-treatment metabolic tumor volume from
    Jung TY; Min JJ; Bom HS; Jung S; Kim IY; Lim SH; Kim DY; Kwon SY
    Neurosurg Rev; 2017 Apr; 40(2):223-229. PubMed ID: 27282449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of 11C-methionine PET in imaging brain tumours and metastases.
    Glaudemans AW; Enting RH; Heesters MA; Dierckx RA; van Rheenen RW; Walenkamp AM; Slart RH
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):615-35. PubMed ID: 23232505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors.
    Schinkelshoek M; Lopci E; Clerici E; Alongi F; Mancosu P; Rodari M; Navarria P; van der Hiel B; Scorsetti M; Chiti A
    Tumori; 2014; 100(6):636-44. PubMed ID: 25688497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
    Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral glioma: evaluation with methionine PET.
    Ogawa T; Shishido F; Kanno I; Inugami A; Fujita H; Murakami M; Shimosegawa E; Ito H; Hatazawa J; Okudera T
    Radiology; 1993 Jan; 186(1):45-53. PubMed ID: 8380108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.
    Langen KJ; Ziemons K; Kiwit JC; Herzog H; Kuwert T; Bock WJ; Stöcklin G; Feinendegen LE; Müller-Gärtner HW
    J Nucl Med; 1997 Apr; 38(4):517-22. PubMed ID: 9098193
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Deuschl C; Kirchner J; Poeppel TD; Schaarschmidt B; Kebir S; El Hindy N; Hense J; Quick HH; Glas M; Herrmann K; Umutlu L; Moenninghoff C; Radbruch A; Forsting M; Schlamann M
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):593-601. PubMed ID: 29282517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas.
    Galldiks N; Kracht LW; Burghaus L; Thomas A; Jacobs AH; Heiss WD; Herholz K
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):516-24. PubMed ID: 16450140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of ¹¹C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions.
    Watanabe A; Muragaki Y; Maruyama T; Shinoda J; Okada Y
    J Neurooncol; 2016 Feb; 126(3):577-83. PubMed ID: 26612734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures.
    Pirotte B; Goldman S; Dewitte O; Massager N; Wikler D; Lefranc F; Ben Taib NO; Rorive S; David P; Brotchi J; Levivier M
    J Neurosurg; 2006 Feb; 104(2):238-53. PubMed ID: 16509498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
    Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
    No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.
    Roessler K; Gatterbauer B; Becherer A; Paul M; Kletter K; Prayer D; Hoeftberger R; Hainfellner J; Asenbaum S; Knosp E
    Minim Invasive Neurosurg; 2007 Oct; 50(5):273-80. PubMed ID: 18058643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
    Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
    Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
    Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
    Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in the (11C-methyl)-L-methionine uptake index in gliomas following radiotherapy].
    Mineura K; Sasajima T; Kowada M; Shishido F; Uemura K
    Gan No Rinsho; 1989 Sep; 35(10):1101-4. PubMed ID: 2789298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
    J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic value of PET using 11C-methionine in patients with untreated cerebral gliomas].
    Svortsova TIu; Brodskaia ZL; Gurchin AF; Gaĭdaenko KP
    Zh Vopr Neirokhir Im N N Burdenko; 2011; 75(4):10-6; discussion 16. PubMed ID: 22379848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds.
    Voges J; Herholz K; Hölzer T; Würker M; Bauer B; Pietrzyk U; Treuer H; Schröder R; Sturm V; Heiss WD
    Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):129-35. PubMed ID: 9711745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
    Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K
    J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sequential analysis of the integrated images of PET, CT and MR in malignant brain tumors before and after radiotherapy].
    Suzuki A; Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Uemura K
    No To Shinkei; 1996 May; 48(5):449-57. PubMed ID: 8672304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.